These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 16398057)

  • 21. Pharmacologic characteristics of a new calcium antagonist, manidipine: beneficial effects on renal circulation and vascular changes.
    Nagaoka A
    Am Heart J; 1993 Feb; 125(2 Pt 2):560-5. PubMed ID: 8430600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.
    Kosaka H; Hirayama K; Yoda N; Sasaki K; Kitayama T; Kusaka H; Matsubara M
    Eur J Pharmacol; 2010 Jun; 635(1-3):49-55. PubMed ID: 20307534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
    Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE
    Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
    Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benidipine, an anti-hypertensive drug, relaxes mouse airway smooth muscle.
    Yang Y; Chen W; Wen N; Cai C; Liu QH; Shen J
    Life Sci; 2019 Jun; 227():74-81. PubMed ID: 31002920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats.
    Sabbatini M; Leonardi A; Testa R; Vitaioli L; Amenta F
    Hypertension; 2000 Mar; 35(3):775-9. PubMed ID: 10720594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
    Sidach SS; Mintz IM
    J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
    Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voltage-dependent calcium channels--beyond dihydropyridine antagonists.
    Snutch TP; Sutton KG; Zamponi GW
    Curr Opin Pharmacol; 2001 Feb; 1(1):11-6. PubMed ID: 11712528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Role of P/Q-type Voltage-gated Calcium Channels: From Transmitter Release to Contraction of Renal Vasculature.
    Hansen PB
    J Cardiovasc Pharmacol; 2015 May; 65(5):406-11. PubMed ID: 25469806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists].
    Hongo K; Yoshimura M
    Clin Calcium; 2010 Jan; 20(1):89-93. PubMed ID: 20048439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB; Al-Mashhadi RH; Cribbs LL; Skøtt O; Hansen PB
    Kidney Int; 2011 Feb; 79(4):443-51. PubMed ID: 21068717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
    Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF
    Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker.
    Yao K; Nagashima K; Miki H
    J Pharmacol Sci; 2006 Apr; 100(4):243-61. PubMed ID: 16565579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of anti-hypertensive drugs on glomerular hemodynamics.
    Ito S; Abe K
    Nihon Jinzo Gakkai Shi; 1996 Mar; 38(3):115-8. PubMed ID: 8721331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.